Recalibration of the limiting antigen avidity EIA to determine mean duration of recent infection in divergent HIV-1 subtypes.
dc.contributor.author | Duong, Y.T. | |
dc.contributor.author | Kassanjee, R. | |
dc.contributor.author | Welte, A. | |
dc.contributor.author | Ampofo, W. | |
dc.contributor.author | Parekh, B.S. | |
dc.contributor.author | Morgan, M. | |
dc.contributor.author | De, A. | |
dc.contributor.author | Dobbs, T. | |
dc.contributor.author | Rottinghaus, E. | |
dc.contributor.author | Nkengasong, J. | |
dc.contributor.author | Curlin, M.E. | |
dc.contributor.author | Kittinunvorakoon, C. | |
dc.contributor.author | Raengsakulrach, B. | |
dc.contributor.author | Martin, M. | |
dc.contributor.author | Choopanya, K. | |
dc.contributor.author | Vanichseni, S. | |
dc.contributor.author | Jiang, Y. | |
dc.contributor.author | Qiu, M. | |
dc.contributor.author | Yu, H. | |
dc.contributor.author | Hao, Y. | |
dc.contributor.author | Shah, N. | |
dc.contributor.author | Le, L.-V. | |
dc.contributor.author | Kim, A.A. | |
dc.contributor.author | Nguyen, T.A. | |
dc.date.accessioned | 2016-07-19T14:34:40Z | |
dc.date.available | 2016-07-19T14:34:40Z | |
dc.date.issued | 2015-02-24 | |
dc.description | Article | en_ZA |
dc.description.abstract | Background: Mean duration of recent infection (MDRI) and misclassification of long-term HIV-1 infections, as proportion false recent (PFR), are critical parameters for laboratory-based assays for estimating HIV-1 incidence. Recent review of the data by us and others indicated that MDRI of LAg-Avidity EIA estimated previously required recalibration. We present here results of recalibration efforts using >250 seroconversion panels and multiple statistical methods to ensure accuracy and consensus. Methods: A total of 2737 longitudinal specimens collected from 259 seroconverting individuals infected with diverse HIV-1 subtypes were tested with the LAg-Avidity EIA as previously described. Data were analyzed for determination of MDRI at ODn cutoffs of 1.0 to 2.0 using 7 statistical approaches and sub-analyzed by HIV-1 subtypes. In addition, 3740 specimens from individuals with infection >1 year, including 488 from patients with AIDS, were tested for PFR at varying cutoffs. Results: Using different statistical methods,MDRI values ranged from 88-94 days at cutoff ODn = 1.0 to 177-183 days at ODn = 2.0. The MDRI values were similar by different methods suggesting coherence of different approaches. Testing formisclassification among long-terminfections indicated that overall PFRs were 0.6%to 2.5%at increasing cutoffs of 1.0 to 2.0, respectively. Balancing the need for a longer MDRI and smaller PFR (<2.0%) suggests that a cutoff ODn = 1.5, corresponding to an MDRI of 130 days should be used for cross-sectional application. The MDRI varied among subtypes from 109 days (subtype A&D) to 152 days (subtype C). Conclusions: Based on the new data and revised analysis, we recommend an ODn cutoff = 1.5 to classify recent and long-term infections, corresponding to an MDRI of 130 days (118-142). Determination of revised parameters for estimation of HIV-1 incidence should facilitate application of the LAg-Avidity EIA for worldwide use. | en_ZA |
dc.description.sponsorship | This research has been supported by the President’s Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC). | en_ZA |
dc.identifier.citation | Duong, Y.T. et al. 2015. Recalibration of the limiting antigen avidity EIA to determine mean duration of recent infection in divergent HIV-1 subtypes. PLoS ONE 10(2): e0114947. | en_ZA |
dc.identifier.issn | 1932-6203 | |
dc.identifier.uri | http://hdl.handle.net/10539/20668 | |
dc.language.iso | en | en_ZA |
dc.publisher | Public Library of Science | en_ZA |
dc.subject | antigen | en_ZA |
dc.subject | accuracy | en_ZA |
dc.subject | acquired immune deficiency syndrome | en_ZA |
dc.subject | analytical parameters | en_ZA |
dc.subject | antigen binding | en_ZA |
dc.subject | controlled study | en_ZA |
dc.subject | disease duration | en_ZA |
dc.subject | enzyme immunoassay | en_ZA |
dc.subject | human | en_ZA |
dc.subject | Human immunodeficiency virus 1 | en_ZA |
dc.subject | Human immunodeficiency virus 1 infection | en_ZA |
dc.subject | limiting antigen vidity | en_ZA |
dc.subject | major clinical study | en_ZA |
dc.subject | mean duration of recent infection | en_ZA |
dc.subject | proportion false recent | en_ZA |
dc.subject | Review | en_ZA |
dc.subject | seroconversion | en_ZA |
dc.subject | statistical analysis | en_ZA |
dc.subject | HIV infections | en_ZA |
dc.subject | BIOLOGICAL assay | en_ZA |
dc.subject | PARAMETER estimation | en_ZA |
dc.subject | LONGITUDINAL method | en_ZA |
dc.subject | DATA analysis | en_ZA |
dc.title | Recalibration of the limiting antigen avidity EIA to determine mean duration of recent infection in divergent HIV-1 subtypes. | en_ZA |
dc.type | Article | en_ZA |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Recalibration of the Limiting Antigen Avidity EIA to Determine Mean Duration of Recent Infection in Divergent HIV-1 Subtypes..pdf
- Size:
- 3.47 MB
- Format:
- Adobe Portable Document Format
- Description:
- Article
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: